Drug
68Ga-FAPI-04
68Ga-FAPI-04 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
3
60%
Ph not_applicable
2
40%
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
3(60.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(1)
Other(4)
Detailed Status
unknown4
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 13 (60.0%)
N/A2 (40.0%)
Trials by Status
completed120%
unknown480%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
NCT07553741
unknownearly_phase_1
68Ga-FAPI PET/CT in Patients With Various Fibrotic Disease
NCT04831034
unknownnot_applicable
68Ga-FAPI-04 PET Imaging in Early Response Evaluation of Rectal Cancer Patients Treated With Immunotherapy
NCT05999227
unknownearly_phase_1
68Ga-FAPI-04 PET/CT for the Detection of Oral Carcinoma
NCT05003427
unknownearly_phase_1
68Ga-FAPI PET/CT in Liver Fibrosis Patients
NCT04533828
Clinical Trials (5)
Showing 5 of 5 trials
NCT07553741Not Applicable
Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
NCT04831034Early Phase 1
68Ga-FAPI PET/CT in Patients With Various Fibrotic Disease
NCT05999227Not Applicable
68Ga-FAPI-04 PET Imaging in Early Response Evaluation of Rectal Cancer Patients Treated With Immunotherapy
NCT05003427Early Phase 1
68Ga-FAPI-04 PET/CT for the Detection of Oral Carcinoma
NCT04533828Early Phase 1
68Ga-FAPI PET/CT in Liver Fibrosis Patients
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5